Pharmafile Logo
Pharmafocus logo
Advanced Search

inflectra

Showing 7 posts of 7 posts found.

What will Pfizer do with its second Remicade biosimilar?

December 14, 2017
Sales and Marketing Ixifi, Johnson & Johnson, Pfizer, Remicade, biosimilars, biotech, drugs, inflectra, pharma, pharmaceutical

Pfizer is now in the unusual position of owning two biosimilars to Johnson & Johnson’s Remicade, though one of these …

News
pfizer-building-logo1web

Switching Crohn’s patients to biosimilar Inflectra from Remicade is safe and effective, Pfizer says

October 30, 2017
Research and Development, Sales and Marketing Crohn’s disease, Pfizer, Remicade, crohn's disease, inflectra, pharma

Pfizer has released new data on its Crohn’s disease (CD) treatment Inflectra (infliximab CT-P13) which indicate that switching patients to …

News
pfizer_brussels

Pfizer’s Remicade biosimilar displays similar efficacy

February 22, 2017
Research and Development Johnson & Johnson, Pfizer, Remicade, inflectra

Pfizer and Celltrion have announced new data for their Remicade biosimilar, Inflectra, that shows that the drug is comparable in …

News
pfizer_sky

Pfizer sets release date for rival to J&J’s blockbuster drug

October 18, 2016
Manufacturing and Production J&J, JJ, Johnson & Johnson, Pfizer, Remicade, inflectra

Pfizer have announced that they will begin shipping their rival to Johnson & Johnson’s Remicade by the end of November. …

News
Hospira image

Data supports switching to Hospira biosimilar for RA

June 10, 2015
Research and Development, Sales and Marketing EULAR, Hospira, Janssen, RA, brett wells, celltrion, inflectra, rome

Findings presented at EULAR this week from the first real-world study in patients with rheumatic diseases supports switching from J&J’s …

News
Hospira image

Hospira launches biosimilar monoclonal antibody

February 16, 2015
Research and Development, Sales and Marketing MSD, Merck, Remicade, biosimilar. hospira, inflectra, infliximab

Hospira has won the race to become the first company to launch a biosimilar version of an anti-TNF biologic, after …

News
Hospira image

Hospira’s Inflectra approved in Europe

September 10, 2013
Research and Development, Sales and Marketing Hospira, Janssen, Remicade, biosimilars, inflectra

Hospira has been the first firm to meet the European Commission’s approval for a biosimilar monoclonal antibody therapy with its …

News

Latest content

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024